HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery.

Abstract
A 36 year-old man, who had undergone a paclitaxel-eluting stent deployment into the left main (LM) coronary artery three years before, was admitted after successful resuscitation following out-of-hospital cardiac arrest due to an acute ST-segment elevation myocardial infarction. Six weeks before the admission, he had discontinued clopidogrel. Coronary angiography showed a total occlusion of the LM artery. A complex percutaneous coronary intervention including thrombectomy and a second everolimus-eluting stent deployment in the LM artery and the left descending coronary artery was performed; this resulted in the restoration of TIMI 2/3 flow. A detailed investigation revealed an essential thrombocytosis necessitating treatment with hydroxyurea and indefinite dual antiplatelet therapy.
AuthorsMarek Prech, Magdalena Janus, Konrad Lukawski, Maciej Lesiak
JournalKardiologia polska (Kardiol Pol) Vol. 71 Issue 3 Pg. 308-9 ( 2013) ISSN: 0022-9032 [Print] Poland
PMID23575792 (Publication Type: Case Reports, Journal Article)
Chemical References
  • clopidogrel
  • Ticlopidine
  • Paclitaxel
Topics
  • Adult
  • Coronary Angiography
  • Coronary Stenosis (etiology, radiography)
  • Coronary Thrombosis (etiology, radiography)
  • Drug-Eluting Stents (adverse effects)
  • Humans
  • Male
  • Myocardial Infarction (etiology, radiography, therapy)
  • Out-of-Hospital Cardiac Arrest (etiology, therapy)
  • Paclitaxel (administration & dosage)
  • Thrombocytosis (drug therapy, etiology)
  • Ticlopidine (administration & dosage, analogs & derivatives)
  • Withholding Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: